KHF Breaking News

Advisories and Breaking News

Kids Health First is closely monitoring COVID-19 updates from the leading authorities across the globe, including:

  • World Health Organization
  • Centers for Disease Control
  • American Academy of Pediatrics
  • American Board of Pediatrics
  • Georgia Department of Public Health
  • Children’s Healthcare of Atlanta, and
  • Other leading authorities.

Please check back often for new developments and community advisories as they become available. 


Recent News Updates:

The CDC expands use of COVID-19 vaccines for children ages 6 months thru 5 years. On Friday, December 9, 2022 the CDC updated the use of the bivalent vaccines from both Moderna and Pfizer BioNTech for children as young as 6 months of age. Click here for more detailed information. 

The CDC expands use of COVID-19 vaccines for ages 5 thru 11 for Pfizer and 6 thru 17 for Moderna. On Wednesday, October 12, 2022 the CDC expanded use of the updated (bivalent) vaccine for both Pfizer-BioNTech and Moderna vaccine for children and adolescents. Click here for more detailed information.

The CDC announces recommendation of the first updated COVID-19 booster. Thursday, September 1. CDC's Rochelle P. Walensky, M.D., M.P.H., endorsed the ACIP's committee recommendations for the updated COVID-19 boosters from Pfizer-BioNTech (ages 12 years and older) and from Moderna (ages 18 years and older). Click here for more information. 

FDA announces amended emergency use authorization of bivalent  COVID Pfizer-BioNTech and Moderna boosters-August 31, 2022 . FDA  announces the EUA approval of bivalent formulations of the vaccines for use as a single booster dose at least two months following primary or booster vaccination for specific age groups. Click here for more information. 

CDC Director Rachel Walensky endorses the ACIP recommendation-June 18,2022 the Advisory Committee on Immunization Practices met to the discuss the FDA's recommendation on the EUA of both the Pfizer-BioNTech and Moderna COVID-19 vaccines for children 6 months thru 5 years of age. Click here for more information. 

FDA is one step closer to EUA of COVID vaccines for children under age 5-June 15, 2022. Click here for more information. 

FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) is tentatively scheduled to meet on June 15, 2022. 

Pfizer-BioNTech reports strong immune response in children under 5 years of age following a third dose of the COVID-19 vaccine-May 23, 2022 Pfizer reported that  "based on toppling data, three doses of the Pfizer-BioNTech COVID-19 Vaccine met all immunobridging criteria required for Emergency Use Authorization." Click here for more information.  

CDC recommends that all individuals age 5 and older receive a COVID-19 vaccine booster- May 19, 2022. Click here for more information. 

FDA expands eligibility for Pfizer-BioNTech COVID-19 vaccine booster for children 5-11 years old-May 17, 2022. Click here for more information. 

CMS announces updates on COVID-19 vaccinations and distribution-May 6, 2022 CMS announced updated recommendations on COVID-19 vaccinations, distribution and Medicaid, and CHIP reporting requirements and implications. Click here for more information. 

Moderna asks the FDA for authorization of its two-dose regimen of the COVID-19 booster in children under the age of 6-April 27,2022 Moderna requested EUA authorization for its COVID-19 vaccine for younger children. Click here for more information. 

Pfizer announces results for COVID-19 booster in children 5-11 years of age-On April 14, 2022. Click here for more information. 

The FDA announces EUA of first breathalyzer test in detecting COVID-April 14, 2022, FDA announced the emergency use authorization of a breathalyzer test that can detect SARS-CoV-2 infection. Click here for more information.  

Moderna announces preliminary results for COVID-19 vaccine for children under 5 years of age-March 23, 2022. Click here for more information.

FDA Delays Approval of COVID vaccine for children under 5-On February 11, 2022, the FDA delayed Pfizer's request to approve the emergency use authorization of their COVID-19 vaccine for children under the age of 5. The FDA is seeking clinical data on the evaluation of a third dose before moving forward. Click here for more information. 

Pfizer-BioNTech Initiates Rolling Submission EAU of COVID vaccine for children under 5-February 1, 2022. Click here for more information. 

AAP addresses parents' concerns about the Omicron variant in a newly released article-January 21, 2022, (www.healthy children.org). Click here for more information.  

Effectiveness of Pfizer-BioNTech Vaccine against MIS-C-January 7, 2022. CDC reported that in a study involving of 24 pediatric hospitals across the country, the Pfizer-BioNTech vaccine showed a high level of effectiveness against MIS-C in children ages 12-18. "Receipt of 2 doses of Pfizer-BioNTech vaccine is highly effective in preventing MIS-C in persons aged 12–18 years. These findings further reinforce the COVID-19 vaccination recommendation for eligible children." Click here for more information. 

CDC updates masking guidelines-January 14, 2022. Click here for more information.

CDC clarifies recommendations for isolation and quarantine-January 9, 2022 CDC clarified its recommendations on isolation and quarantine for those exposed to, or positive for COVID-19. Click here for those updated guidelines. 

CDC expands booster shot eligibility for 12-17 year olds-January 5, 2022 CDC endorsed the ACIP recommendation to expand eligibility of booster doses to 12-17-year-olds, five months after initial Pfizer-BioNTech vaccination series. Click here for more information.

FDA authorizes first booster for COVID-19 for 12-15 yr. olds-January 3, 2022. FDA authorized a booster of the Pfizer COVID-19 vaccine for children ages 12-15. Click here for more information.

CNN reports 16- and 17-year-olds are now eligible for a Pfizer/BioNTech Covid-19 vaccine booster-On December 9, 2021 CNN reported that the US Food and Drug Administration authorized the Pfizer/BioNTech Covid-19 vaccine for use as a booster in people ages 16 and 17, and the US Centers for Disease Control and Prevention recommended it for this age group. Click here for more information.

CDC: Booster Vaccines-On November 29, 2021 the CDC announced that everyone over the age of 18 should receive a COVID-19 booster vaccine. Click here for more information.

CDC: What you need to know about variants-On November 27, 2021, the CDC explains what you need to know about variants, including the newly identified Omicron variant. As of this date, no known cases of the Omicron variant have been discovered in the U.S. Stay tuned for developing news.  Click here for more information.

CDC: Interim Guidance for Fully Vaccinated People-November 19, 2021.  Click here to view the updated recommendations.

CDC: The Center for Disease Control advises vaccines for children ages 5-11-November 2, 2021. Click here for more information.

Pfizer: COVID-19 vaccine produces significant immune response in children ages 5-11 years-September 20, 2021 “We are encouraged by Pfizer-BioNTech’s announcement and look forward to reviewing the data from the clinical trial,” said AAP President Lee Savio Beers, M.D., FAAP.  Click here for more information.

American Academy of Pediatrics Cautions Against Off-label Use of COVID-19 Vaccines in Children Under 12- August 23,2021.  Click here for more information. 


10.28.20Ransomware Activity Targeting the Healthcare and Public Health Sector

The Cybersecurity and Infrastructure Security Agency (CISA), the Federal Bureau of Investigation (FBI), and the U.S. Department of Health and Human Services (HHS) have credible information of an increased and imminent cybercrime threat to U.S. hospitals and healthcare providers.

CISA, FBI, and HHS have released AA20-302A Ransomware Activity Targeting the Healthcare and Public Health Sector that details both the threat and practices that healthcare organizations should continuously engage in to help manage the risk posed by ransomware and other cyber threats. The advisory references the joint CISA MS-ISAC Ransomware Guide that provides a ransomware response checklist that can serve as a ransomware-specific addendum to organization cyber incident response plans.

In addition to these materials regarding the most recent ransomware threat to the Healthcare and Public Health Sector, the HHS Office for Civil Rights’ Fact Sheet: Ransomware and HIPAA provides further information for entities regulated by the HIPAA Rules.

CISA, FBI, and HHS are sharing this information in order to provide a warning to healthcare providers to ensure that they take timely and reasonable precautions to protect their networks from these threats. CISA encourages users and administrators to review CISA’s Ransomware webpage for additional information.

HHS Revises Definition of “Lost Revenue,” Clarifies Definition of “Reporting Entity,” and Expands Phase III Eligibility

On October 22, the Department of Health and Human Services (HHS) issued revised instructions regarding permitted uses of Provider Relief Fund (PRF) payments. The legislation creating the PRF restricts its use to “healthcare-related expenses or lost revenues that are attributable to coronavirus” and requires recipients to report on their use of funds. Read our detailed explanation of the HHS revisions here.


The Georgia AAP Releases The Pediatrician’s Toolkit for School Re-Entry and Children’s Health in the Time of COVID-19– June 2020

The Georgia Chapter of the American Academy of Pediatrics (AAP) School Health Committee has developed a toolkit that can serve as a template for how the pediatrician can become involved in school re-openings.

New Report: U.S. Schools Have Avoided Spike in COVID-19 Cases

Reuters recently reported Friday, Oct. 2, that U.S. schools from kindergarten to high school have avoided a spike in COVID-19 cases, noting reassuring data that shows you can open schools safely when you put in place the right measures and have control of community spread. Medical experts say the real test is coming as students in large densely-populated cities such as New York and Miami return to classrooms.


GA AAP – 9.30.20

  • Update on CPT Code 87426 – The Chapter learned last week that the Georgia Department of Community Health (Medicaid) is reimbursing CPT code 87426 at a “default rate” of $15 until CMS sets a rate for this code. Once the rate has been set, Georgia Medicaid will have all Fee for Service claims reprocessed at the higher rate.
  • Flu Vaccine Bidirectional Borrowing – Georgia VFC has announced they will allow borrowing between VFC and private flu vaccine stocks for the 2020-2021 flu season.  Please refer to the recently released guidance here.
  • AAP Updates Guidance on Returning to Sports Activities –  On September 17th, the AAP updated its guidance for children and teens who participate in sports activities, clarifying the recommended amount of time athletes should be held out of practices and games if they or close contacts show symptoms or test + for COVID-19.

Health Inequity in the Hispanic/Latinx Population During the COVID-19 Pandemic– 9/2/20


The Georgia AAP Releases The Pediatrician’s Toolkit for School Re-Entry and Children’s Health in the Time of COVID-19– June 2020

The Georgia Chapter of the American Academy of Pediatrics (AAP) School Health Committee has developed a toolkit that can serve as a template for how the pediatrician can become involved in school re-openings.

We do capture site browsing history to improve our website for future visitors!